{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:50:11Z","timestamp":1772819411512,"version":"3.50.1"},"reference-count":158,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2011,6,30]]},"DOI":"10.18632\/oncotarget.285","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:51:58Z","timestamp":1442440318000},"page":"435-447","source":"Crossref","is-referenced-by-count":41,"title":["Elevated PI3K signaling drives multiple Breast Cancer subtypes"],"prefix":"10.18632","volume":"2","author":[{"given":"Jessica R.","family":"Adams","sequence":"first","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 101 College St., East Tower"},{"name":"The Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}]},{"given":"Nathan F.","family":"Schachter","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 101 College St., East Tower"},{"name":"The Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}]},{"given":"Jeff C.","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Cell and Molecular Biology, Toronto General Research Institute-University Health Network, Toronto, Ontario, Canada"}]},{"given":"Eldad","family":"Zacksenhaus","sequence":"additional","affiliation":[{"name":"Division of Cell and Molecular Biology, Toronto General Research Institute-University Health Network, Toronto, Ontario, Canada"},{"name":"The Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"}]},{"given":"Sean E.","family":"Egan","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 101 College St., East Tower"},{"name":"The Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}]}],"member":"7892","published-online":{"date-parts":[[2011,6,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Cantley","year":"2008","journal-title":"Oncogene"},{"key":"2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/332644a0","article-title":"Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate","volume":"332","author":"Cantley","year":"1988","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/MCB.18.3.1379","article-title":"Regulation of the p85\/p110 phosphatidylinositol 3\u2019-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit","volume":"18","author":"Backer","year":"1998","journal-title":"Mol Cell Biol"},{"key":"4","first-page":"351","article-title":"Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling","volume":"80","author":"Liu","year":"2009","journal-title":"Vitam Horm"},{"key":"5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bies.950190608","article-title":"The IRS-signalling system during insulin and cytokine action","volume":"19","author":"White","year":"1997","journal-title":"Bioessays"},{"key":"6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/MCB.22.3.965-977.2002","article-title":"Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival","volume":"22","author":"Kahn","year":"2002","journal-title":"Mol Cell Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)80226-3","article-title":"Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras","volume":"89","author":"Downward","year":"1997","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2007.03.051","article-title":"Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice","volume":"129","author":"Downward","year":"2007","journal-title":"Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2005.02.010","article-title":"Recent advances in the protein kinase B signaling pathway","volume":"17","author":"Woodgett","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Cantley","year":"2007","journal-title":"Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Sabatini","year":"2009","journal-title":"J Cell Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1016\/j.cub.2009.09.058","article-title":"An emerging role of mTOR in lipid biosynthesis","volume":"19","author":"Sabatini","year":"2009","journal-title":"Curr Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sabatini","year":"2007","journal-title":"Mol Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Manning","year":"2008","journal-title":"Biochem J"},{"key":"16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Manning","year":"2010","journal-title":"Mol Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","article-title":"Transcriptional Control of Cellular Metabolism by mTOR Signaling","volume":"71","author":"Manning","year":"2011","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00109-011-0726-6","article-title":"mTOR links oncogenic signaling to tumor cell metabolism","volume":"89","author":"Manning","year":"2011","journal-title":"J Mol Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","article-title":"mTOR and cancer: many loops in one pathway","volume":"22","author":"Sabatini","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Sabatini","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molcel.2011.03.017","article-title":"Rac1 Regulates the Activity of mTORC1 and mTORC2 and Controls Cellular Size","volume":"42","author":"Carpenter","year":"2011","journal-title":"Mol Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Sabatini","year":"2006","journal-title":"Dev Cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/0008-5472.CAN-07-5869","article-title":"Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival","volume":"68","author":"Dedhar","year":"2008","journal-title":"Cancer Res"},{"key":"24","article-title":"Integrin-linked kinase: Not so \u2018pseudo\u2019 after all","author":"Dedhar","year":"2011","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"e12356","DOI":"10.1371\/journal.pone.0012356","article-title":"Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3beta (GSK-3beta) phosphorylation","volume":"5","author":"Dedhar","year":"2010","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1073\/pnas.95.19.11211","article-title":"Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B\/AKT by the integrin-linked kinase","volume":"95","author":"Dedhar","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.devcel.2010.09.007","article-title":"Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae","volume":"19","author":"Fassler","year":"2010","journal-title":"Dev Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc1524","article-title":"Integrin-linked kinase: a cancer therapeutic target unique among its ILK","volume":"5","author":"Dedhar","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3410\/B2-82","article-title":"Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?","volume":"2","author":"Woodgett","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Rosen","year":"2011","journal-title":"Cancer Cell"},{"key":"31","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Wigler","year":"1997","journal-title":"Science"},{"key":"32","first-page":"3657","article-title":"Mutation analysis of the putative tumor suppressor gene PTEN\/MMAC1 in primary breast carcinomas","volume":"57","author":"Boyd","year":"1997","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Mak","year":"1998","journal-title":"Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.95.23.13513","article-title":"The lipid phosphatase activity of PTEN is critical for its tumor supressor function","volume":"95","author":"Tonks","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/0008-5472.CAN-07-1182","article-title":"The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration","volume":"68","author":"Durden","year":"2008","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ncb1847","article-title":"Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction","volume":"11","author":"Wei","year":"2009","journal-title":"Nat Cell Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2010.12.020","article-title":"Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner","volume":"144","author":"Pandolfi","year":"2011","journal-title":"Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2009.06.006","article-title":"Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling","volume":"16","author":"Cantley","year":"2009","journal-title":"Cancer Cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2008.12.002","article-title":"PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt","volume":"136","author":"Taya","year":"2009","journal-title":"Cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","article-title":"PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth","volume":"18","author":"Newton","year":"2005","journal-title":"Mol Cell"},{"key":"41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Sabatini","year":"2009","journal-title":"Cell"},{"key":"42","article-title":"Breast Cancer Special Feature: Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors","author":"Arteaga","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"43","doi-asserted-by":"crossref","first-page":"pe4","DOI":"10.1126\/stke.2682005pe4","article-title":"Ser\/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance","volume":"2005","author":"Zick","year":"2005","journal-title":"Sci STKE"},{"key":"44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2005.09.027","article-title":"Phosphoinositide 3-kinase: from viral oncoprotein to drug target","volume":"344","author":"Kang","year":"2006","journal-title":"Virology"},{"key":"45","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/onc.2008.244","article-title":"Class I PI3K in oncogenic cellular transformation","volume":"27","author":"Vogt","year":"2008","journal-title":"Oncogene"},{"key":"46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Velculescu","year":"2004","journal-title":"Science"},{"key":"47","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1158\/0008-5472.CAN-05-2612","article-title":"Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells","volume":"65","author":"Brugge","year":"2005","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1073\/pnas.0712169105","article-title":"Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms","volume":"105","author":"Vogt","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-08-0755","article-title":"PIK3CA cooperates with other phosphatidylinositol 3\u2019-kinase pathway mutations to effect oncogenic transformation","volume":"68","author":"McCormick","year":"2008","journal-title":"Cancer Res"},{"key":"50","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1073\/pnas.181181198","article-title":"A phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus","volume":"98","author":"Donner","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1101-973","article-title":"HER-2\/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation","volume":"3","author":"Hung","year":"2001","journal-title":"Nat Cell Biol"},{"key":"52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Mak","year":"2001","journal-title":"Mol Cell"},{"key":"53","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Nikolsky","year":"2007","journal-title":"Science"},{"key":"54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4161\/cbt.3.8.994","article-title":"The PIK3CA gene is mutated with high frequency in human breast cancers","volume":"3","author":"Park","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"55","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Phillips","year":"2004","journal-title":"Cancer Res"},{"key":"56","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/0008-5472-CAN-04-3913","article-title":"PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma","volume":"65","author":"Parsons","year":"2005","journal-title":"Cancer Res"},{"key":"57","doi-asserted-by":"crossref","first-page":"R609","DOI":"10.1186\/bcr1262","article-title":"Somatic mutation and gain of copy number of PIK3CA in human breast cancer","volume":"7","author":"Sidransky","year":"2005","journal-title":"Breast Cancer Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1158\/0008-5472.CAN-09-0064","article-title":"Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res"},{"key":"59","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.onc.1210202","article-title":"The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer","volume":"26","author":"Muller","year":"2007","journal-title":"Oncogene"},{"key":"60","doi-asserted-by":"crossref","first-page":"16224","DOI":"10.1073\/pnas.0808041105","article-title":"Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers","volume":"105","author":"Kopelovich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ijc.24831","article-title":"PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality","volume":"126","author":"Sutherland","year":"2010","journal-title":"Int J Cancer"},{"key":"62","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.humpath.2009.02.005","article-title":"Dysregulated PI3K\/Akt\/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma","volume":"40","author":"Collecchi","year":"2009","journal-title":"Hum Pathol"},{"key":"63","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer","volume":"68","author":"Hung","year":"2008","journal-title":"Cancer Res"},{"key":"64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Swain","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bjc.6604463","article-title":"Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype","volume":"99","author":"Ellis","year":"2008","journal-title":"Br J Cancer"},{"key":"66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/bcr2617","article-title":"The Met oncogene and basal-like breast cancer: another culprit to watch out for?","volume":"12","author":"Trusolino","year":"2010","journal-title":"Breast Cancer Res"},{"key":"67","article-title":"The met receptor tyrosine kinase and basal breast cancer","volume":"9","author":"Park","year":"2010","journal-title":"Cell Cycle"},{"key":"68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1078-0432.CCR-06-1371","article-title":"Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis","volume":"13","author":"Reis-Filho","year":"2007","journal-title":"Clin Cancer Res"},{"key":"69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-811X-7-22","article-title":"Function, regulation and pathological roles of the Gab\/DOS docking proteins","volume":"7","author":"Brummer","year":"2009","journal-title":"Cell Commun Signal"},{"key":"70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0962-8924(03)00002-3","article-title":"The \u201cGab\u201d in signal transduction","volume":"13","author":"Neel","year":"2003","journal-title":"Trends Cell Biol"},{"key":"71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Lee","year":"2007","journal-title":"Science"},{"key":"72","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yexcr.2007.10.013","article-title":"Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae","volume":"314","author":"Seo","year":"2008","journal-title":"Exp Cell Res"},{"key":"73","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.onc.1208337","article-title":"Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling","volume":"24","author":"Liscovitch","year":"2005","journal-title":"Oncogene"},{"key":"74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/en.2007-0312","article-title":"Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts","volume":"149","author":"Maggi","year":"2008","journal-title":"Endocrinology"},{"key":"75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/gcc.2870110110","article-title":"The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer","volume":"11","author":"Malfoy","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"76","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature08489","article-title":"Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution","volume":"461","author":"Moore","year":"2009","journal-title":"Nature"},{"key":"77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10911-008-9101-9","article-title":"Insulin receptor substrates (IRSs) and breast tumorigenesis","volume":"13","author":"Lee","year":"2008","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccr.2009.10.016","article-title":"Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation","volume":"16","author":"Wu","year":"2009","journal-title":"Cancer Cell"},{"key":"79","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nm1341","article-title":"A role for the scaffolding adapter GAB2 in breast cancer","volume":"12","author":"Gu","year":"2006","journal-title":"Nat Med"},{"key":"80","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-09-0820","article-title":"3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"key":"81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Tucker-Kellogg","year":"2007","journal-title":"Nature"},{"key":"82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2007.07.014","article-title":"A new mutational AKTivation in the PI3K pathway","volume":"12","author":"Mills","year":"2007","journal-title":"Cancer Cell"},{"key":"83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2011.02.003","article-title":"Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase","volume":"144","author":"Gygi","year":"2011","journal-title":"Cell"},{"key":"84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Dennis","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"85","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1006273516976","article-title":"Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype","volume":"57","author":"Bonilla","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/gcc.20062","article-title":"Promoter methylation of the PTEN gene is a common molecular change in breast cancer","volume":"41","author":"Bonilla","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"87","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.3880371","article-title":"Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer","volume":"14","author":"Ross","year":"2001","journal-title":"Mod Pathol"},{"key":"88","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9440(10)65227-3","article-title":"Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast","volume":"155","author":"Eng","year":"1999","journal-title":"Am J Pathol"},{"key":"89","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1172\/JCI32533","article-title":"IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland","volume":"117","author":"Bonafe","year":"2007","journal-title":"J Clin Invest"},{"key":"90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Struhl","year":"2009","journal-title":"Cell"},{"key":"91","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Struhl","year":"2010","journal-title":"Mol Cell"},{"key":"92","article-title":"HER2 overexpression elicits a pro-inflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis","author":"Lyerly","year":"2011","journal-title":"Cancer Res"},{"key":"93","doi-asserted-by":"crossref","first-page":"40057","DOI":"10.1074\/jbc.M303621200","article-title":"Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase\/AKT cascades","volume":"278","author":"Mills","year":"2003","journal-title":"J Biol Chem"},{"key":"94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients","volume":"6","author":"Yu","year":"2004","journal-title":"Cancer Cell"},{"key":"95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.18632\/oncotarget.260","article-title":"INPP4B: the New Kid on the PI3K Block","volume":"2","author":"Ittmann","year":"2011","journal-title":"Oncotarget"},{"key":"96","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(10)70176-5","article-title":"Clinical implementation of the intrinsic subtypes of breast cancer","volume":"11","author":"Bernard","year":"2010","journal-title":"Lancet Oncol"},{"key":"97","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1073\/pnas.0912708107","article-title":"A pathway-based classification of human breast cancer","volume":"107","author":"Nevins","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"98","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Perou","year":"2010","journal-title":"Breast Cancer Res"},{"key":"99","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-08-3441","article-title":"Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics","volume":"69","author":"Monteagudo","year":"2009","journal-title":"Cancer Res"},{"key":"100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-008-0197-9","article-title":"Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis","volume":"117","author":"Reis-Filho","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Corless","year":"2010","journal-title":"Mod Pathol"},{"key":"102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yexmp.2009.09.016","article-title":"PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast","volume":"88","author":"Zhu","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-009-0406-1","article-title":"Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma","volume":"120","author":"Troxell","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"104","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","author":"Pietenpol","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"105","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1158\/1078-0432.CCR-07-0266","article-title":"Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas","volume":"13","author":"Marchetti","year":"2007","journal-title":"Clin Cancer Res"},{"key":"106","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1158\/0008-5472.CAN-09-1968","article-title":"Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase","volume":"69","author":"Backer","year":"2009","journal-title":"Cancer Res"},{"key":"107","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/bcr2204","article-title":"Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells","volume":"10","author":"Thiery","year":"2008","journal-title":"Breast Cancer Res"},{"key":"108","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ng.2007.39","article-title":"Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair","volume":"40","author":"Memeo","year":"2008","journal-title":"Nat Genet"},{"key":"109","doi-asserted-by":"crossref","first-page":"22231","DOI":"10.1073\/pnas.1015245107","article-title":"Inositol polyphosphate 4-phosphatase II regulates PI3K\/Akt signaling and is lost in human basal-like breast cancers","volume":"107","author":"Majerus","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer","volume":"12","author":"Bernards","year":"2007","journal-title":"Cancer Cell"},{"key":"111","article-title":"Upregulation of MIR-21 mediates resistance to trastuzumab therapy for breast cancer","author":"Song","year":"2011","journal-title":"J Biol Chem"},{"key":"112","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/1535-7163.MCT-09-1171","article-title":"Activated phosphoinositide 3-kinase\/AKT signaling confers resistance to trastuzumab but not lapatinib","volume":"9","author":"Slamon","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"113","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/onc.2010.257","article-title":"H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3","volume":"29","author":"Arteaga","year":"2010","journal-title":"Oncogene"},{"key":"114","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"Glazer","year":"2007","journal-title":"Genome Biol"},{"key":"115","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1172\/JCI41490","article-title":"Rb deletion in mouse mammary progenitors induces luminal-B or basal-like\/EMT tumor subtypes depending on p53 status","volume":"120","author":"Zacksenhaus","year":"2010","journal-title":"J Clin Invest"},{"key":"116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10911-010-9184-y","article-title":"The pathology of EMT in mouse mammary tumorigenesis","volume":"15","author":"Cardiff","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"117","first-page":"250","article-title":"Mouse models of human breast cancer","volume":"53","author":"Cardiff","year":"2003","journal-title":"Comp Med"},{"key":"118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2127","article-title":"Insights from transgenic mouse models of ERBB2-induced breast cancer","volume":"7","author":"Muller","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"119","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1158\/0008-5472.CAN-10-0738","article-title":"Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation","volume":"71","author":"Egan","year":"2011","journal-title":"Cancer Res"},{"key":"120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Berns","year":"2001","journal-title":"Nat Genet"},{"key":"121","article-title":"Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors","author":"Bentires-Alj","year":"2011","journal-title":"Cancer Res"},{"key":"122","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1210\/mend.15.6.0663","article-title":"Mammary gland involution is delayed by activated Akt in transgenic mice","volume":"15","author":"Anderson","year":"2001","journal-title":"Mol Endocrinol"},{"key":"123","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1128\/MCB.21.6.2203-2212.2001","article-title":"Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression","volume":"21","author":"Muller","year":"2001","journal-title":"Mol Cell Biol"},{"key":"124","first-page":"3605","article-title":"High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+\/\u2212 mice","volume":"60","author":"Mak","year":"2000","journal-title":"Cancer Res"},{"key":"125","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1242\/dev.129.17.4159","article-title":"Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland","volume":"129","author":"Wu","year":"2002","journal-title":"Development"},{"key":"126","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.onc.1209955","article-title":"Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation","volume":"26","author":"Moorehead","year":"2007","journal-title":"Oncogene"},{"key":"127","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1038\/onc.2010.231","article-title":"Preneoplastic changes persist after IGF-IR downregulation and tumor regression","volume":"29","author":"Moorehead","year":"2010","journal-title":"Oncogene"},{"key":"128","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1158\/0008-5472.CAN-03-3465","article-title":"Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion","volume":"64","author":"Muller","year":"2004","journal-title":"Cancer Res"},{"key":"129","doi-asserted-by":"crossref","first-page":"19018","DOI":"10.1074\/jbc.M109.018937","article-title":"PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis","volume":"284","author":"Muller","year":"2009","journal-title":"J Biol Chem"},{"key":"130","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.cellsig.2010.07.011","article-title":"PI3-kinase p110alpha mediates beta1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading","volume":"22","author":"Johansson","year":"2010","journal-title":"Cell Signal"},{"key":"131","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Slamon","year":"2003","journal-title":"Cancer Res"},{"key":"132","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.200505087","article-title":"Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition","volume":"171","author":"Brugge","year":"2005","journal-title":"J Cell Biol"},{"key":"133","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/0008-5472.CAN-06-3782","article-title":"Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2\/neu and MMTV-polyoma middle T transgenic mice","volume":"67","author":"Tsichlis","year":"2007","journal-title":"Cancer Res"},{"key":"134","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1158\/0008-5472.CAN-10-0266","article-title":"Distinct biological roles for the akt family in mammary tumor progression","volume":"70","author":"Muller","year":"2010","journal-title":"Cancer Res"},{"key":"135","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-08-4287","article-title":"Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression","volume":"69","author":"Muller","year":"2009","journal-title":"Cancer Res"},{"key":"136","doi-asserted-by":"crossref","first-page":"36443","DOI":"10.1074\/jbc.M600788200","article-title":"Opposing roles for Akt1 and Akt2 in Rac\/Pak signaling and cell migration","volume":"281","author":"Field","year":"2006","journal-title":"J Biol Chem"},{"key":"137","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","article-title":"The Akt kinases: isoform specificity in metabolism and cancer","volume":"8","author":"McGraw","year":"2009","journal-title":"Cell Cycle"},{"key":"138","first-page":"ra62","article-title":"MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells","volume":"2","author":"Tsichlis","year":"2009","journal-title":"Sci Signal"},{"key":"139","article-title":"Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation","author":"Tsichlis","year":"2011","journal-title":"Cancer Res"},{"key":"140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","article-title":"PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms","volume":"25","author":"Newton","year":"2007","journal-title":"Mol Cell"},{"key":"141","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2009.04.012","article-title":"AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer","volume":"16","author":"Gupta","year":"2009","journal-title":"Cancer Cell"},{"key":"142","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/me.2010-0294","article-title":"SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells","volume":"25","author":"Chen","year":"2011","journal-title":"Mol Endocrinol"},{"key":"143","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1038\/sj.onc.1204910","article-title":"Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice","volume":"20","author":"Muller","year":"2001","journal-title":"Oncogene"},{"key":"144","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/onc.2010.86","article-title":"Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer","volume":"29","author":"Muller","year":"2010","journal-title":"Oncogene"},{"key":"145","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"Borg","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"146","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature09781","article-title":"Cells of origin in cancer","volume":"469","author":"Visvader","year":"2011","journal-title":"Nature"},{"key":"147","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4161\/cc.9.22.13936","article-title":"Both lipid- and protein-phosphatase activities of PTEN contribute to the p53-PTEN anti-invasion pathway","volume":"9","author":"Mak","year":"2010","journal-title":"Cell Cycle"},{"key":"148","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.2309","article-title":"Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways","volume":"17","author":"Yu","year":"2011","journal-title":"Nat Med"},{"key":"149","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1073\/pnas.0812000106","article-title":"Specific function of phosphoinositide 3-kinase beta in the control of DNA replication","volume":"106","author":"Carrera","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"150","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1074\/jbc.M109.085696","article-title":"Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits","volume":"285","author":"Balk","year":"2010","journal-title":"J Biol Chem"},{"key":"151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00428-010-0881-0","article-title":"PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer","volume":"456","author":"Schmitt","year":"2010","journal-title":"Virchows Arch"},{"key":"152","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.207","article-title":"A beta version of life: p110beta takes center stage","volume":"1","author":"Backer","year":"2010","journal-title":"Oncotarget"},{"key":"153","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.1016132108","article-title":"I{kappa}B kinase {varepsilon} and TANK-binding kinase 1 activate AKT by direct phosphorylation","volume":"108","author":"Guan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"154","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"Hirozane-Kishikawa","year":"2007","journal-title":"Cell"},{"key":"155","doi-asserted-by":"crossref","first-page":"530","DOI":"10.18632\/oncotarget.188","article-title":"Targeting the PI3K\/Akt\/mTOR pathway-beyond rapalogs","volume":"1","author":"Tabernero","year":"2010","journal-title":"Oncotarget"},{"key":"156","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1073\/pnas.0810221106","article-title":"Igf1r as a therapeutic target in a mouse model of basal-like breast cancer","volume":"106","author":"Efstratiadis","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"157","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature07782","article-title":"Tumours with PI3K activation are resistant to dietary restriction","volume":"458","author":"Sabatini","year":"2009","journal-title":"Nature"},{"key":"158","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ccr.2011.03.012","article-title":"Defective Regulation of Autophagy upon Leucine Deprivation Reveals a Targetable Liability of Human Melanoma Cells In Vitro and In Vivo","volume":"19","author":"Sabatini","year":"2011","journal-title":"Cancer Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T23:23:19Z","timestamp":1653175399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,5]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["285","21646685"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.285","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,5]]}}}